PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'ChemRar High-Tech Center, Khimki, Moscow region, Russian Federation.\', \'Russian Direct Investment Fund, Moscow, Russian Federation.\', \'IPHARMA LLC, Skolkovo Innovative Centre, Moscow, Russian Federation.\', \'Chromis LLC, Skolkovo Innovative Centre, Moscow, Russian Federation.\', \'City Clinical Hospital n.a. O.M. Filatov, Moscow, Russian Federation.\', \'Department of Chemistry and Technology, Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation.\', \'Department of Biology, Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation.\', \'Central Clinical Hospital with Polyclinic, Moscow, Russian Federation.\', \'Department of Finished Dosage Forms, Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation.\', \'Moscow State University n.a. M. V. Lomonosov, Moscow, Russian Federation.\', \'Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation.\', \'Clinical Hospital No.1, Smolensk, Russian Federation.\', \'First Moscow State Medical University n.a. I.M. Sechenov, Moscow, Russian Federation.\', \'Infectious clinical hospital No. 2, Nizhny Novgorod, Russian Federation.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/cid/ciaa1176
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 32770240
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32770240>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32770240>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all